Cambium Medical Technologies LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2013-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.cambiumbio.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease
Phase 1
Completed
- Conditions
- Dry EyeGraft-versus-host-diseaseOcular Discomfort
- First Posted Date
- 2018-01-30
- Last Posted Date
- 2021-07-27
- Lead Sponsor
- Cambium Medical Technologies LLC
- Target Recruit Count
- 64
- Registration Number
- NCT03414645
- Locations
- 🇺🇸
Byers Eye Institute of Stanford University, Palo Alto, California, United States
🇺🇸Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
🇺🇸University of Michigan - Kellogg Clinical Research Center, Ann Arbor, Michigan, United States
News
No news found